PALO ALTO, Calif.--(BUSINESS WIRE)--Affymax, Inc. (Nasdaq:AFFY) will host a teleconference and webcast on Monday, July 16, 2007, at 10:00 a.m. Eastern time to review its Hematide™ clinical development program. Hematide is the company’s lead drug in development for the treatment of anemia.
